Literature DB >> 9918692

RNA-Mediated interference of a cdc25 homolog in Caenorhabditis elegans results in defects in the embryonic cortical membrane, meiosis, and mitosis.

N R Ashcroft1, M Srayko, M E Kosinski, P E Mains, A Golden.   

Abstract

The CDC25 dual-specificity phosphatase family has been shown to play a key role in cell cycle regulation. The phosphatase activity of CDC25 drives the cell cycle by removing inhibitory phosphates from cyclin-dependent kinase/cyclin complexes. Although the regulation of CDC25 phosphatase activity has been elucidated both biochemically and genetically in other systems, the role of this enzyme during development is not well understood. To examine the expression pattern and function of CDC25 in Caenorhabditis elegans, we characterized a cdc25 homolog, cdc-25.1, during early embryonic development. The CDC-25.1 protein localizes to oocytes, embryonic nuclei, and embryonic cortical membranes. When the expression of CDC-25.1 was disrupted by RNA-mediated interference, the anterior cortical membrane of fertilized eggs became very fluid during meiosis and subsequent mitotic cell cycles. Mispositioning of the meiotic spindle, defects in polar body extrusion and chromosome segregation, and abnormal cleavage furrows were also observed. We conclude that CDC-25.1 is required for a very early developmental process-the proper completion of meiosis prior to embryogenesis. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9918692     DOI: 10.1006/dbio.1998.9135

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  19 in total

Review 1.  Cdc25 as a potential target of anticancer agents.

Authors:  J W Eckstein
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

2.  CDC-25.2, a C. elegans ortholog of cdc25, is essential for the progression of intestinal divisions.

Authors:  Yong-Uk Lee; Miseol Son; Jiyoung Kim; Yhong-Hee Shim; Ichiro Kawasaki
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

3.  Oncogenic potential of a C.elegans cdc25 gene is demonstrated by a gain-of-function allele.

Authors:  Caroline Clucas; Juan Cabello; Ingo Büssing; Ralf Schnabel; Iain L Johnstone
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

Review 4.  Developmental Control of the Cell Cycle: Insights from Caenorhabditis elegans.

Authors:  Edward T Kipreos; Sander van den Heuvel
Journal:  Genetics       Date:  2019-03       Impact factor: 4.562

5.  A conserved role for a GATA transcription factor in regulating epithelial innate immune responses.

Authors:  Michael Shapira; Brigham J Hamlin; Jiming Rong; Karen Chen; Michal Ronen; Man-Wah Tan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-12       Impact factor: 11.205

Review 6.  In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets.

Authors:  Hiroaki Kiyokawa; Dipankar Ray
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

7.  Caenorhabditis elegans cyclin B3 is required for multiple mitotic processes including alleviation of a spindle checkpoint-dependent block in anaphase chromosome segregation.

Authors:  Gary M R Deyter; Tokiko Furuta; Yasuhiro Kurasawa; Jill M Schumacher
Journal:  PLoS Genet       Date:  2010-11-24       Impact factor: 5.917

8.  A mutation of cdc-25.1 causes defects in germ cells but not in somatic tissues in C. elegans.

Authors:  Jiyoung Kim; Ah-Reum Lee; Ichiro Kawasaki; Susan Strome; Yhong-Hee Shim
Journal:  Mol Cells       Date:  2009-06-12       Impact factor: 5.034

9.  Control of cell cycle timing during C. elegans embryogenesis.

Authors:  Zhirong Bao; Zhongying Zhao; Thomas J Boyle; John I Murray; Robert H Waterston
Journal:  Dev Biol       Date:  2008-03-13       Impact factor: 3.582

10.  Fate specification and tissue-specific cell cycle control of the Caenorhabditis elegans intestine.

Authors:  Alexandra Segref; Juan Cabello; Caroline Clucas; Ralf Schnabel; Iain L Johnstone
Journal:  Mol Biol Cell       Date:  2010-01-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.